Pancreatic Cancer Research

ResearcherSt. Jude Children's Research HospitalActive in the last 2 years

Taosheng Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6420-3809; OpenAlex author ID A5004064976. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers

Papers 4

  1. CYP3A5 unexpectedly regulates glucose metabolism through the AKT-TXNIP-GLUT1 axis in pancreatic cancer. Last author DOI 10.1016/j.gendis.2023.101079↗
  2. Pancreatic cancer organoid-screening captures personalized sensitivity and chemoresistance suppression upon cytochrome P450 3A5-targeted inhibition. Last author DOI 10.1016/j.isci.2024.110289↗
  3. KANSL2 and MBNL3 are regulators of pancreatic ductal adenocarcinoma invasion. Last author DOI 10.1038/s41598-020-58448-y↗
  4. Genome-wide CRISPR screen reveals PSMA6 to be an essential gene in pancreatic cancer cells. Last author DOI 10.1186/s12885-019-5455-1↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Meritxell B. Cutrona · 1 shared paper, 2024 · strength 0.28
  2. Jesse Bakke · 2 shared papers, 2019–2020 · strength 0.26
  3. Peter O. Oladimeji · 2 shared papers, 2019–2020 · strength 0.26
  4. Ming Shao · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.